(Q44884410)

7 December 2017

title

Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application (English)

1 reference

7 December 2017

8

Robert A Kloner

1 reference

7 December 2017

2

Joseph M Arcidi

1 reference

7 December 2017

1

Hyosook Hwang

1 reference

7 December 2017

4

Boris Z Simkhovich

1 reference

7 December 2017

6

Arvinder K Dhalla

1 reference

7 December 2017

Sharon L Hale

3

1 reference

7 December 2017

Luiz Belardinelli

series ordinal

5

1 reference

7 December 2017

John C Shryock

series ordinal

7

1 reference

7 December 2017

publication date

27 March 2009

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

7 December 2017

published in

1 reference

7 December 2017

volume

14

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

125-133

1 reference

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Late sodium current inhibition as a new cardioprotective approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Pathophysiology and pharmacology of the cardiac "late sodium current.".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemic-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Cardiac allograft preservation using donor-shed blood supplemented with L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Broad-spectrum cardioprotection with adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Cellular mechanisms of ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Myocardial cell damage in "stone hearts".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248409333491

21 January 2018

Identifiers

DOI

10.1177/1074248409333491

1 reference

7 December 2017

1 reference